new developments at ash | rafat abonour, md | ash 2022
Published 1 year ago • 549 plays • Length 2:10
Download video MP4
Download video MP3
Similar videos
-
3:44
bispecific t cell engagers | noopur raje, md | ash 2022
-
1:38
what to look forward to at ash | ola landgren, md, phd | ash 2022
-
1:44
post bcma therapy | gurbakhash kaur, md | ash 2022
-
3:19
revlimid refractory patients in daratumumab clinical trials | binod dhakal, md | ash 2022
-
5:40
nutrivention trials | urvi shah, md | ash 2022
-
2:55
ash 2019: the optimum trial | dr. martin kaiser
-
21:38
new developments in endovascular
-
9:33
talquetamab | ajai chari, md | ash 2022
-
6:02
brain tumors 101: surgical options after a brain tumor diagnosis
-
6:50
bispecifics | urvi shah, md | ash 2022
-
3:19
dr. richard baz at ash 2022: abstract no. 3251
-
1:15
patient top concerns at and since diagnosis | nathan sweeney, phd | ash 2022
-
10:01
building a dietary evidence symposium | urvi shah, md | ash 2022
-
4:22
maintenance cessation in mrd negative patients | neha korde, md | ash 2022
-
5:19
who should get mrd testing?
-
3:42
prospective evaluation of the biology of aggressive myeloma lesions after induction | ash 2022
-
3:11
bispecific antibodies | joshua richter, md | ash 2022
-
5:29
updates on teclistamab, talquetamab, and carvykti | mark wildgust, phd | ash 2022
-
2:11
detecting myeloma with single cell sequencing | scott goldsmith, md | ash 2022
-
1:05
insights into connect® mm & the need for better designed clinical trials
-
4:21
new and promising clinical trials presented at ash 2019
Clip.africa.com - Privacy-policy